Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 15771848

[Pharmacy].

Ana Herranz Alonso·Lourdes Caro González·Isabel Castillo Romera·María Sanjurjo Sáez·Camino Sarobe González
View original source ↗Export metadata ↓

Abstract

After learning of the scale of the terrorist attacks on 11th March, the main goal of the Pharmacy Service was to guarantee the availability of drugs to meet the needs of a large number of patients in as short a time as possible. Due to an automated storage system, drugs could be ordered from the pharmacuetical laboratories efficiently. One hundred fifty-seven orders for drugs were made, representing an increase of 51% over the daily average. As far as possible, burocratic procedures were avoided. In addition, dispensation of drugs to admission wards was facilitated by an automatic storage and dispensation system (carousels). A total of 249 distinct orders were dispensed (2,755 drugs), concentrated in the Resuscitation and Intensive Care Units, Emergency and Surgical Departments, representing 100% of the activity performed from 8.30 to 13.00 h. After that time, normal dispensing activity to the other clinical units was resumed.

Explore related subjects

Drug UtilizationHealth Services AccessibilityHospitals, UniversityHumansMass Casualty IncidentsMedication Systems, HospitalPharmacy Service, HospitalSpainEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ana Herranz Alonso, Lourdes Caro González, Isabel Castillo Romera, María Sanjurjo Sáez, Camino Sarobe González. 2005-03-01. [Pharmacy].. https://doi.org/10.1157/13072649

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Reasons why few patients with acute stroke receive tissue plasminogen activator.

Despite the US Food and Drug Administration's approval in 1996, tissue plasminogen activator (tPA) therapy for acute ischemic stroke remains substantially underused. We reviewed 3 potential reasons for low rates of tPA use: poor patient education, physicians' perceived risk of legal liability from negative patient outcomes, and insufficient reimbursement. The recent addition of diagnosis-related grouping code 559 will provide higher payment for stroke patients treated with tPA, creating a natural experiment to examine our third reason.

Drug Utilization↗
PubMed2006

Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy.

BACKGROUND: Patients with psoriasis undergoing or about to undergo ultraviolet (UV) phototherapy and photochemotherapy often have thick scale on their plaques which can prevent the penetration of UV radiation. Emollients are used to moisturize the skin and to prevent or reduce some of the milder side-effects ('dryness', itching) sometimes experienced during UV therapy. However, emollients can alter the UV transmission of skin and thus may alter the clinical effects of phototherapy and photochemotherapy. OBJECTIVES: We tested 30 of the topical emollients in the British National Formulary (BNF) using a standard in vitro technique used to test sunscreens. We also surveyed U.K. phototherapy units to establish routine practice for emollient use in phototherapy and photochemotherapy. METHODS: We used a standard in vitro technique to measure the monochromatic protection factors (MPFs) of 30 non-bath emollients from the BNF. An application rate of 2 mg cm-2 was used. For the assessment of effects during narrowband UVB (TL-01) phototherapy, the mean of the protection factors at 310 and 315 nm was calculated; for psoralen plus UVA photochemotherapy the mean UVA protection factor was used. A questionnaire survey was used to assess routine practice concerning emollient use prior to phototherapies in phototherapy units throughout the U.K. RESULTS: In the UVA range, 17 of the 30 emollients gave protection factors of 1.2 or above. In the UVB range, 23 of 30 had an MPF of 1.2 or above. Yellow soft paraffin had the highest protection factor in the UVB range. Of 78 centres surveyed, 57 returned completed questionnaires (73%). Seventeen of 57 (30%) centres routinely used emollients immediately prior to administering phototherapy treatments. The remaining 40 of 57 (70%) did not. Forty-five (79%) responding centres recommended the use of emollients after phototherapy. CONCLUSIONS: This study has revealed considerable variability in the practice of emollient use before phototherapy treatments. Although the majority of centres included in this study did not routinely use emollients, almost one third did. Our in vitro measurement of 30 emollients revealed marked variation in UV transmission, with many emollients blocking sufficient UV to affect the response to therapy.

Drug Utilization↗